HCA Healthcare, Inc.

BOVESPA:H1CA34 Stock Report

Market Cap: R$468.0b

HCA Healthcare Management

Management criteria checks 2/4

HCA Healthcare's CEO is Sam Hazen, appointed in Jan 2019, has a tenure of 5.92 years. total yearly compensation is $21.32M, comprised of 7.1% salary and 92.9% bonuses, including company stock and options. directly owns 0.52% of the company’s shares, worth R$2.45B. The average tenure of the management team and the board of directors is 5.9 years and 8.9 years respectively.

Key information

Sam Hazen

Chief executive officer

US$21.3m

Total compensation

CEO salary percentage7.1%
CEO tenure5.9yrs
CEO ownership0.5%
Management average tenure5.9yrs
Board average tenure8.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Sam Hazen's remuneration changed compared to HCA Healthcare's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$6b

Jun 30 2024n/an/a

US$6b

Mar 31 2024n/an/a

US$5b

Dec 31 2023US$21mUS$2m

US$5b

Sep 30 2023n/an/a

US$6b

Jun 30 2023n/an/a

US$6b

Mar 31 2023n/an/a

US$6b

Dec 31 2022US$15mUS$2m

US$6b

Sep 30 2022n/an/a

US$5b

Jun 30 2022n/an/a

US$7b

Mar 31 2022n/an/a

US$7b

Dec 31 2021US$21mUS$1m

US$7b

Sep 30 2021n/an/a

US$7b

Jun 30 2021n/an/a

US$5b

Mar 31 2021n/an/a

US$5b

Dec 31 2020US$30mUS$1m

US$4b

Sep 30 2020n/an/a

US$3b

Jun 30 2020n/an/a

US$3b

Mar 31 2020n/an/a

US$3b

Dec 31 2019US$27mUS$1m

US$4b

Sep 30 2019n/an/a

US$3b

Jun 30 2019n/an/a

US$4b

Mar 31 2019n/an/a

US$4b

Dec 31 2018US$10mUS$1m

US$4b

Sep 30 2018n/an/a

US$3b

Jun 30 2018n/an/a

US$3b

Mar 31 2018n/an/a

US$3b

Dec 31 2017US$10mUS$1m

US$2b

Compensation vs Market: Sam's total compensation ($USD21.32M) is above average for companies of similar size in the BR market ($USD5.71M).

Compensation vs Earnings: Sam's compensation has increased by more than 20% in the past year.


CEO

Sam Hazen (64 yo)

5.9yrs

Tenure

US$21,315,984

Compensation

Mr. Samuel N. Hazen, also known as Sam, serves as Director at HCA Healthcare, Inc. He serves as Chief Executive Officer of HCA Healthcare Inc. since January 01, 2019 and has been its Director since Septemb...


Leadership Team

NamePositionTenureCompensationOwnership
Samuel Hazen
CEO & Director5.9yrsUS$21.32m0.52%
R$ 2.4b
Jon Foster
Executive VP & COO1.9yrsUS$8.70m0.073%
R$ 341.9m
Erol Akdamar
President of American Group11.9yrsUS$5.40m0.050%
R$ 235.2m
Timothy McManus
President of National Group8.4yrsUS$5.58m0.011%
R$ 49.9m
Thomas Frist
Founder & Chairman Emeritusno dataUS$362.11k0.19%
R$ 884.9m
Michael Marks
CFO & Executive Vice Presidentless than a yearno data0.028%
R$ 128.8m
Christopher Wyatt
Senior VP8.7yrsno data0.016%
R$ 74.7m
Chad Wasserman
Senior VP & Chief Information Officerless than a yearno data0.00062%
R$ 2.9m
Michael McAlevey
Executive VP and Chief Legal & Administrative Officer2.9yrsUS$6.47m0.0016%
R$ 7.4m
Frank Morgan
Vice President of Investor Relations2.9yrsno datano data
Kathleen Whalen
Senior VP and Chief Ethics & Compliance Officer5.9yrsno data0.0037%
R$ 17.5m
Deborah Reiner
Senior Vice President of Marketing & Corporate Affairs7.2yrsno data0.0014%
R$ 6.5m

5.9yrs

Average Tenure

60yo

Average Age

Experienced Management: H1CA34's management team is seasoned and experienced (5.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Samuel Hazen
CEO & Director6.3yrsUS$21.32m0.52%
R$ 2.4b
Thomas Frist
Founder & Chairman Emeritusno dataUS$362.11k0.19%
R$ 884.9m
Michael Michelson
Independent Director6.9yrsUS$389.78k0%
R$ 0
Robert Dennis
Independent Director10.8yrsUS$377.95k0.0016%
R$ 7.5m
Nancy-Ann DeParle
Independent Director10.8yrsUS$334.78k0.0080%
R$ 37.2m
Thomas Frist
Chairman of the Board18.9yrsUS$399.61kno data
Meg Crofton
Independent Director5.8yrsUS$319.78k0.0025%
R$ 11.7m
Hugh Johnston
Independent Director3.3yrsUS$339.78k0.0010%
R$ 4.9m
Wayne Riley
Independent Director12.9yrsUS$349.78k0.0043%
R$ 20.0m
William Frist
Director15.9yrsUS$309.70k0.16%
R$ 749.5m
Andrea Smith
Independent Director2.9yrsUS$324.78k0.0014%
R$ 6.6m
John McWilliams
Director of HealthONEno datano datano data

8.9yrs

Average Tenure

65yo

Average Age

Experienced Board: H1CA34's board of directors are considered experienced (8.9 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 04:48
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

HCA Healthcare, Inc. is covered by 49 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Hua HaBaird
Ishan MajumdarBaptista Research